Anca Associated Vasculitis clinical trials

Explore recruiting anca associated vasculitis clinical trials.

Recruiting anca associated vasculitis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Anca Associated Vasculitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Imlifidase in ANCA-associated Vasculitis

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Anti-CD 19 CAR-T cell therapy in patients with ANCA Vasculitis: A two-stage interventional, prospective, open-label, phase I/II trial in patients with active, treatment refractory, ANCA-IgG-positive vasculitis

Germany

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Discontinuation of rituximab compared with rituximab maintenance in ANCA-associated vasculitis – a randomized non-blinded controlled trial (DISRITUX)

Sweden, Denmark, Ireland, Austria, Iceland, Netherlands +1 more

Therapeutic use (Phase IV) EU CTIS Study details

Avacopan added to standard-of-care therapy in ANCA-associated vasculitis with severe kidney involvement: a randomized, placebo-controlled, double-blinded multicenter superiority study

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A multicenter randomized trial to evaluate the efficacy of pioglitazone to promote renal tolerance in ANCA-associated vasculitis - RENATO

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Double-blind, Placebo-controlled Phase 4 Clinical Trial to Evaluate the Long-term Safety and Efficacy of Avacopan in participants With Antineutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis

Romania, Hungary, Czechia, Poland, Denmark, France +1 more

Therapeutic use (Phase IV) EU CTIS Study details

Anca Associated Vasculitis trials by city

Anca Associated Vasculitis in Toronto Anca Associated Vasculitis in Vancouver Anca Associated Vasculitis in Montreal Anca Associated Vasculitis in Calgary Anca Associated Vasculitis in Edmonton Anca Associated Vasculitis in Ottawa Anca Associated Vasculitis in Winnipeg Anca Associated Vasculitis in Quebec City Anca Associated Vasculitis in Hamilton Anca Associated Vasculitis in Kitchener Anca Associated Vasculitis in London Anca Associated Vasculitis in Halifax Anca Associated Vasculitis in New York Anca Associated Vasculitis in Los Angeles Anca Associated Vasculitis in Chicago Anca Associated Vasculitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease